Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells

Wei Guo,Lin Jia,Ling Xie,Juliann G. Kiang,Yangyang Wang,Fengfei Sun,Zunwen Lin,Enwen Wang,Yida Zhang,Peigen Huang,Ting Sun,Xiao Zhang,Zhengying Bian,Tiejun Tang,Jingtian Guo,Soldano Ferrone,Xinhui Wang

DOI: https://doi.org/10.1038/s41419-024-06644-3

2024-04-28

Cell Death and Disease

Abstract:Irradiation (IR) induces immunogenic cell death (ICD) in tumors, but it rarely leads to the abscopal effect (AE); even combining IR with immune checkpoint inhibitors has shown only anecdotal success in inducing AEs. In this study, we aimed to enhance the IR-induced immune response and generate reproducible AEs using the anti-alcoholism drug, disulfiram (DSF), complexed with copper (DSF/Cu) to induce tumor ICD. We measured ICD in vitro and in vivo. In mouse tumor models, DSF/Cu was injected intratumorally followed by localized tumor IR, creating an in situ cancer vaccine. We determined the anticancer response by primary tumor rejection and assessed systemic immune responses by tumor rechallenge and the occurrence of AEs relative to spontaneous lung metastasis. In addition, we analyzed immune cell subsets and quantified proinflammatory and immunosuppressive chemokines/cytokines in the tumor microenvironment (TME) and blood of the vaccinated mice. Immune cell depletion was investigated for its effects on the vaccine-induced anticancer response. The results showed that DSF/Cu and IR induced more potent ICD under hypoxia than normoxia in vitro. Low-dose intratumoral (i.t.) injection of DSF/Cu and IR(12Gy) demonstrated strong anti-primary and -rechallenged tumor effects and robust AEs in mouse models. These vaccinations also increased CD8 + and CD4 + cell numbers while decreasing Tregs and myeloid-derived suppressor cells in the 4T1 model, and increased CD8 + , dendritic cells (DC), and decreased Treg cell numbers in the MCa-M3C model. Depleting both CD8 + and CD4 + cells abolished the vaccine's anticancer response. Moreover, vaccinated tumor-bearing mice exhibited increased TNFα levels and reduced levels of immunosuppressive chemokines/cytokines. In conclusion, our novel approach generated an anticancer immune response that results in a lack of or low tumor incidence post-rechallenge and robust AEs, i.e., absence of or decreased spontaneous lung metastasis in tumor-bearing mice. This approach is readily translatable to clinical settings and may increase IR-induced AEs in cancer patients.

cell biology

What problem does this paper attempt to address?

The main objective of this paper is to develop a method that can enhance the immune response induced by radiotherapy (IR) and produce reproducible distant effects (abscopal effect, AE). The authors attempt to transform the sporadic anti-cancer immune response induced by radiotherapy into a reproducible in situ cancer vaccine by using the anti-alcoholism drug disulfiram (DSF) in combination with copper (Cu) to enhance the immunogenic cell death (ICD) of tumor cells.

Specifically, the researchers conducted the following work:
1. **In vitro experiments**: They first tested the effects of the DSF/Cu complex on mouse and human breast cancer cell lines in vitro and evaluated the immunogenic cell death characteristics of these cells, including the exposure of calreticulin (CRT) on the cell surface, the decrease in intracellular ATP levels, and the release of high mobility group box 1 (HMGB1).
2. **In vivo experiments**: Next, they established a breast cancer model in mice and created an in situ cancer vaccine by locally injecting the DSF/Cu complex in combination with radiotherapy. The researchers assessed the anti-tumor effects of this method on the primary tumor and its impact on untreated distant tumors, i.e., the so-called abscopal effect.
3. **Immune response evaluation**: Furthermore, the researchers analyzed the changes in immune cell subsets in vaccinated mice, including the increase in the number of CD8+ T cells and CD4+ T cells, and the decrease in regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs). Additionally, they measured the changes in the levels of pro-inflammatory and immunosuppressive cytokines/chemokines in the blood and tumor microenvironment.

In summary, this study aims to enhance the immunogenic cell death of breast cancer cells by combining the DSF/Cu complex with radiotherapy, thereby boosting the host's anti-tumor immune response and ultimately achieving the abscopal effect to reduce or prevent tumor recurrence and metastasis. This strategy has the potential to be translated into clinical applications to enhance the abscopal effect of radiotherapy in cancer patients.